Literature DB >> 22533670

SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.

Albert Giralt1, Francesc Villarroya.   

Abstract

SIRT3 is a member of the sirtuin family of protein deacetylases that is preferentially localized to mitochondria. Prominent among the proteins targeted by SIRT3 are enzymes involved in energy metabolism processes, including the respiratory chain, tricarboxylic acid cycle, fatty acid β-oxidation and ketogenesis. Through these actions, SIRT3 controls the flow of mitochondrial oxidative pathways and, consequently, the rate of production of reactive oxygen species. In addition, SIRT3-mediated deacetylation activates enzymes responsible for quenching reactive oxygen species, and thereby exerts a profound protective action against oxidative stress-dependent pathologies, such as cardiac hypertrophy and neural degeneration. SIRT3 also plays a role in multiple additional metabolic processes, from acetate metabolism to brown adipose tissue thermogenesis, often by controlling mitochondrial pathways through the deacetylation of target enzymes. In general, SIRT3 activity and subsequent control of enzymes involved in energy metabolism is consistent with an overall role of protecting against age-related diseases. In fact, experimental and genetic evidence has linked SIRT3 activity with increased lifespan. In the coming years, the identification of drugs and nutrients capable of increasing SIRT3 expression or modulating SIRT3 activity can be expected to provide promising strategies for ameliorating the metabolic syndrome and other oxidative stress-related diseases that appear preferentially with aging, such as cancer, cardiac dysfunction and neural degeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533670     DOI: 10.1042/BJ20120030

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  105 in total

1.  Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle.

Authors:  Yoshitake Cho; Bethany C Hazen; Paulo G Gandra; Samuel R Ward; Simon Schenk; Aaron P Russell; Anastasia Kralli
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

2.  Sirtuin 3: A major control point for obesity-related metabolic diseases?

Authors:  Sean A Newsom; Kristen E Boyle; Jacob E Friedman
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

Review 3.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

4.  The diversity of histone versus nonhistone sirtuin substrates.

Authors:  Paloma Martínez-Redondo; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2013-03

5.  Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Wenxiu Yang; Yan Zou; Man Zhang; Nan Zhao; Qi Tian; Min Gu; Wei Liu; Rui Shi; Yang Lü; Weihua Yu
Journal:  Neurochem Res       Date:  2015-06-05       Impact factor: 3.996

Review 6.  Aging and uremia: Is there cellular and molecular crossover?

Authors:  William E White; Muhammad M Yaqoob; Steven M Harwood
Journal:  World J Nephrol       Date:  2015-02-06

7.  Epigenetic Regulation of Metabolism and Inflammation by Calorie Restriction.

Authors:  Diego Hernández-Saavedra; Laura Moody; Guanying Bianca Xu; Hong Chen; Yuan-Xiang Pan
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

8.  Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

Authors:  Gregory B Waypa; Scott W Osborne; Jeremy D Marks; Sara K Berkelhamer; Jyothisri Kondapalli; Paul T Schumacker
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

9.  Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.

Authors:  Songtao Li; Xiaobing Dou; Hua Ning; Qing Song; Wei Wei; Ximei Zhang; Chen Shen; Jiaxin Li; Changhao Sun; Zhenyuan Song
Journal:  Hepatology       Date:  2017-07-20       Impact factor: 17.425

10.  Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.

Authors:  C-L Song; H Tang; L-K Ran; B C B Ko; Z-Z Zhang; X Chen; J-H Ren; N-N Tao; W-Y Li; A-L Huang; J Chen
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.